Note: Ingredients listed on restricted chemical lists
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
General Information
Revision date
2021-11-04
Product name
GSK1265744B PAEDIATRIC 5 MG DISPERSIBLE TABLET CORES
Product Synonyms
CABOTEGRAVIR * CABOTEGRAVIR SODIUM * GSK1265744B PEDIATRIC 5 MG DISPERSIBLE
1.2.1 Relevant identified uses
Investigational Medicinal Product
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H411
Hazard statements
Code
Statements
H411
Toxic to aquatic life with long lasting effects
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Environmental hazards
Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Caution - Pharmaceutical agent. Not classified for health hazards. However, occupational exposure to the mixture or substance(s) may cause adverse health effects. See section 11 of the SDS for additional information on health hazards. Dangerous for the environment if discharged into watercourses.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
CABOTEGRAVIR SODIUM, HYDROXYPROPYL METHYL CELLULOSE, MICROCRYSTALLINE CELLULOSE, SUCRALOSE
Signal word
None.
Hazard statements
H411 Toxic to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment.
Response
P391 Collect spillage.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
57.889 % of the mixture consists of component(s) of unknown acute oral toxicity. 75.51 % of the mixture consists of component(s) of unknown acute dermal toxicity. 70.997 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 60.997 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.